Skp2: a dream target in the coming age of cancer therapy

Affiliations

• 1 Department of Molecular and Cellular Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USA.
• 2 Department of Experimental Therapeutics; The University of Texas MD Anderson Cancer Center; Houston, TX USA; The University of Texas Graduate School of Biomedical Sciences at Houston; Houston, TX USA.
• 3 Department of Molecular and Cellular Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USA; The University of Texas Graduate School of Biomedical Sciences at Houston; Houston, TX USA; Graduate Institute of Basic Medical Science; China Medical University; Taichung, Taiwan; Department of Biotechnology; Asia University; Taichung, Taiwan.